Guiling Li
Impact in
- Pharmaceutical Science top 2%
- Advancements in Transdermal Drug Delivery
- Geriatrics and Gerontology top 5%
- Sirtuins and Resveratrol in Medicine
Papers in
-
- Mitochondrial Function and Pathology 6
- Bacterial biofilms and quorum sensing 5
- RNA Interference and Gene Delivery 5
-
- MicroRNA in disease regulation 10
- Co-authors
- Kai‐Fu Tang (12 shared papers)Jingwen Liu (17 shared papers)Xinru Li (7 shared papers)Jian Li (14 shared papers)Xinyou Xie (8 shared papers)Yanzhong Wang (5 shared papers)YiJiang Song (8 shared papers)Miriam L. Greenberg (3 shared papers)
- Journals
- PLoS ONE (5 papers)Journal of Biological Chemistry (4 papers)Journal of Clinical Oncology (4 papers)Carcinogenesis (4 papers)Food Bioscience (3 papers)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Guiling Li
120 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 120
- Pharmaceutical Science 165
- Geriatrics and Gerontology 83
- Cancer Research 274
- Molecular Biology 1.0k
- Hepatology 106
Countries citing papers authored by Guiling Li
This map shows the geographic impact of Guiling Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guiling Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guiling Li more than expected).
Fields of papers citing papers by Guiling Li
This network shows the impact of papers produced by Guiling Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guiling Li. The network helps show where Guiling Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Guiling Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 127 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 126 | |
| 2 | 2014 | 122 | |
| 3 | 2012 | 112 | |
| 4 | 2014 | 65 | |
| 5 | 2015 | 59 | |
| 6 | 2016 | 55 | |
| 7 | 2014 | 52 | |
| 8 | 2006 | 51 | |
| 9 | 2016 | 49 | |
| 10 | 2015 | 47 | |
| 11 | 2013 | 47 | |
| 12 | 2013 | 45 | |
| 13 | 2021 | 44 | |
| 14 | 2019 | 43 | |
| 15 | 2019 | 39 | |
| 16 | 2007 | 39 | |
| 17 | 2013 | 39 | |
| 18 | 2022 | 35 | |
| 19 | 2013 | 34 | |
| 20 | 2021 | 34 |
About Guiling Li
Guiling Li is a scholar working on Molecular Biology, Cancer Research, Epidemiology, Molecular Medicine and Plant Science, having authored 127 papers that have together received 2.1k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (10 papers), Mitochondrial Function and Pathology (6 papers), Bacteriophages and microbial interactions (6 papers), Bacterial biofilms and quorum sensing (5 papers), Liver Disease Diagnosis and Treatment (5 papers), Curcumin's Biomedical Applications (5 papers), Pharmacological Effects of Natural Compounds (5 papers) and RNA Interference and Gene Delivery (5 papers). The work is most often cited by research in Pharmaceutical Science (165 citations), Geriatrics and Gerontology (83 citations), Cancer Research (274 citations), Molecular Biology (1.0k citations) and Hepatology (106 citations). Guiling Li has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Kai‐Fu Tang, Jingwen Liu, Xinru Li, Jian Li, Xinyou Xie, Yanzhong Wang, YiJiang Song, Miriam L. Greenberg, Zhujun Deng and Yan Liu. Their work appears in journals such as PLoS ONE, Journal of Biological Chemistry, Journal of Clinical Oncology, Carcinogenesis and Food Bioscience.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.